Chemoinformaics analysis of Matairesinol-4-O-Beta-Glucopyranoside
| Molecular Weight | 520.531 | nRot | 9 |
| Heavy Atom Molecular Weight | 488.275 | nRig | 24 |
| Exact Molecular Weight | 520.194 | nRing | 4 |
| Solubility: LogS | -3.239 | nHRing | 2 |
| Solubility: LogP | 0.526 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 73.5794 |
| nHD | 5 | BPOL | 41.6506 |
| QED | 0.286 |
| Synth | 4.166 |
| Natural Product Likeliness | 1.88 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.144 |
| HIA | 0.669 |
| CACO-2 | -5.964 |
| MDCK | 0.000057 |
| BBB | 0.429 |
| PPB | 0.827431 |
| VDSS | 0.419 |
| FU | 0.145723 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.254 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.819 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.48 |
| CYP2d6-inh | 0.032 |
| CYP2d6-sub | 0.831 |
| CYP3a4-inh | 0.175 |
| CYP3a4-sub | 0.25 |
| CL | 11.114 |
| T12 | 0.633 |
| hERG | 0.11 |
| Ames | 0.185 |
| ROA | 0.04 |
| SkinSen | 0.06 |
| Carcinogencity | 0.59 |
| EI | 0.007 |
| Respiratory | 0.015 |
| NR-Aromatase | 0.757 |
| Antiviral | Yes |
| Prediction | 0.925771 |